logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

NSCLC: adding bevacizumab ups survival with carboplatin-pemetrexed

Better survival benefit in advanced nonsquamous NSCLC, even after adjusting for confounders.